-
Check your clinic storeroom for stock of the Sandoz oral contraceptive Introvale. The Princeton, NJ-based company issued a voluntary recall in June 2012 for 10 lots of the generic oral contraceptive following a recent report of a packaging flaw.
-
Patients who received treatment for depression within a year were identified in a Japanese database of more than 323,000 patients. The investigators asked 2354 patients to complete a questionnaire on depression with a specific focus on patient-physician relationships.
-
In this issue: Side effects of finasteride; new ruling on pharmaceutical companies paying generic manufacturers; and FDA actions.
-
Several studies have implicated endometriosis as a risk factor for the subsequent development of invasive epithelial ovarian cancer.
-
Results of primary studies on and meta-analyses of the effects of vitamin D therapy on fracture risk have failed to conclusively demonstrate benefit.
-
Through the contraceptive choice project, the authors performed a prospective cohort study in which 9256 women living in the region surrounding St. Louis, Missouri, received a reversible contraceptive method of their choice for up to 3 years at no cost.
-
Every so often, one runs across a paper that is somewhat offbeat, but could have some beneficial clinical implications. One such article appeared recently in the British Journal of Obstetrics and Gynecology that dealt with a way to possibly counter the fetal effects of maternal hyperthermia and even protect the brains of fetuses/infants against potential hypoxic insult during labor.
-
-
Many women might consider use of the intrauterine device (IUD) for contraception, but some might shy away from choosing the method due to fear of pain during insertion.
-
Throughout the first half of 2012, debate raged in Washington and in the media over a new requirement under the Affordable Care Act that most private health plans provide coverage of contraceptive methods and counseling without additional out-of-pocket costs, such as copayments and deductibles.